Stock Splits Scheduled for This Week (November 10 to November 14) – Keep Your Investments Active
Upcoming Stock Splits: The week of November 10 to November 14 will see stock splits, including a 1-for-10 reverse split by iOThree Limited and a 1-for-5 reverse split by LXP Industrial Trust, both aimed at complying with Nasdaq's listing requirements.
Understanding Stock Splits: A stock split increases the number of shares while maintaining the company's market value, making shares more affordable, whereas a reverse stock split reduces the number of shares to boost the price per share, often to meet exchange requirements.
Company Profiles: iOThree Limited specializes in maritime digital technologies, while LXP Industrial Trust focuses on Class A industrial warehouse properties, both adapting their share structures to enhance market positioning.
Investor Insights: Monitoring stock splits and reverse splits can provide investors with insights into a company's financial health and strategic intentions, potentially offering an investment edge.
Trade with 70% Backtested Accuracy
Analyst Views on IOTR
About IOTR
About the author


- Significant Performance Growth: iOThree achieved a revenue of $14.7 million in FY2026, marking a 40% increase, with gross profit rising by 68.4%, reflecting the resilience of its business model and customer trust; despite a net loss of $1.2 million due to expansion costs, this was reduced to $0.6 million when excluding one-off listing expenses.
- Strong Market Demand: The demand for digital solutions in the maritime sector continues to grow, particularly in active markets like Singapore and Taiwan, with iOThree's edge computing and SaaS services becoming the primary revenue drivers, solidifying the company's leading position in digital transformation.
- Ongoing Product Innovation: The company is developing an AI-powered analytics platform focused on multi-fuel optimization and carbon reporting, with plans to launch a shipboard digital bulletin board service in Q3 2026, enhancing its competitive edge and meeting customer needs.
- Geographic Expansion Strategy: iOThree is accelerating its entry into the Japanese market, with its office expected to be operational by Q4 2026, bringing the company closer to one of the world's significant maritime markets and further driving business growth.
- Fiscal Year Revenue Growth: iOThree Limited reported FY revenue of $14.7 million, reflecting a robust 40% year-over-year increase, indicating strong market demand for its products or services.
- Net Loss Situation: Despite the revenue growth, iOThree recorded a net loss of $1.2 million for the fiscal year, highlighting cost pressures faced during expansion, which necessitates attention to future profitability.
- Adjusted Loss Analysis: Excluding one-off listing expenses, the net loss would be reduced to $0.6 million, underscoring the company's potential in controlling operational costs, which could lay the groundwork for future financial improvement.
- Market Outlook: With significant revenue growth and potential cost optimization, iOThree is positioned to achieve profitability in the future, attracting more investor interest in its long-term development strategy.

- Market Uptrend: U.S. stocks traded higher this morning, with the Dow Jones gaining around 300 points, or 0.63%, reflecting optimistic sentiment towards economic recovery, which may attract more investor interest.
- P&G's Strong Performance: Procter & Gamble reported Q2 adjusted EPS of $1.88, beating the analyst consensus of $1.86, although quarterly sales of $22.208 billion fell short of the expected $22.282 billion, indicating the company's efforts in cost control amidst mixed results.
- Notable Stock Surges: Shares of 60 Degrees Pharmaceuticals skyrocketed 297% to $7.94 after announcing a partnership with Runway Health to expand pre-departure access to ARAKODA, demonstrating strong market reaction to new collaborations.
- Energy Sector Decline: Despite the overall market rise, energy stocks dipped 0.4% on Wednesday, suggesting potential challenges in supply-demand balance within the sector, prompting investors to monitor future market dynamics.
- Successful Financing: High Roller Technologies Inc announced the completion of a registered direct offering of 1.89 million common shares at $13.21 per share, raising approximately $25 million in gross proceeds, significantly enhancing the company's liquidity to support future business expansion.
- Stock Surge: Following this announcement, High Roller’s shares jumped 29.6% to $10.21 in pre-market trading, reflecting strong market confidence in the company's growth potential and likely attracting more investor interest.
- Positive Market Reaction: The successful financing not only improves High Roller’s capital structure but also positions the company to gain a stronger competitive edge in the fiercely competitive online gaming market, aiding in further market share expansion.
- Strategic Growth Outlook: With this financing, High Roller Technologies can accelerate its strategic plans, including technological innovation and market expansion, which is expected to bring long-term growth opportunities and enhance shareholder value.
- Significant Stock Surge: PainReform Ltd. shares rose 27.4% to $1.02 in pre-market trading following the announcement of a name change and expansion into diversified healthcare and AI-driven energy platforms, indicating strong market confidence in its new strategy.
- Diversification Strategy: The name change reflects the company's strategic shift towards healthcare and energy sectors, aiming to attract more investors and enhance brand recognition, thereby strengthening its competitive position in the market.
- Market Movements: In pre-market trading, Acco Group Holdings saw a staggering 219.4% increase, highlighting strong investor interest in high-growth potential companies, which may influence perceptions of other related stocks.
- Industry Trends: As the integration of healthcare and energy sectors accelerates, PainReform's strategic adjustments align with industry developments and could provide the company with long-term growth opportunities.

- Bioavailability Improvement: Gelteq Ltd's oral gel delivery platform achieved over a 22% increase in bioavailability compared to an FDA-approved oil-based product in preclinical trials, indicating significant technological advantages that could enhance market acceptance and drive future sales growth.
- Stock Surge: Following this positive announcement, Gelteq's shares surged 50.1% in pre-market trading to $1.25, reflecting strong investor confidence in the new technology and its market potential.
- Enhanced Market Competitiveness: By improving product bioavailability, Gelteq not only meets the growing consumer demand but also positions itself more favorably in the competitive pharmaceutical market, potentially driving the company's long-term strategic development.
- Increased Investor Interest: With Gelteq's technological advancements and stock price increase, market attention on its future performance has significantly risen, likely attracting more investors and partners, thereby facilitating the company's capital operations and business expansion.








